Cargando…
TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells
Glioblastoma is the most common type of primary brain tumor in adults, with high mortality and morbidity rates. More effective therapeutic strategies are imperative. Previous studies have shown that the known p110-β-selective inhibitor TGX-221 blocks the activation of PKB/Akt in PTEN-deficient cells...
Autores principales: | Yang, Xue, Yang, Ji-An, Liu, Bao-Hui, Liao, Jian-Ming, Yuan, Fan-En, Tan, Yin-Qiu, Chen, Qian-Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780035/ https://www.ncbi.nlm.nih.gov/pubmed/29048665 http://dx.doi.org/10.3892/or.2017.5991 |
Ejemplares similares
-
PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways
por: Feng, Chenchen, et al.
Publicado: (2015) -
PI3Kβ inhibitor AZD6482 exerts antiproliferative activity and induces apoptosis in human glioblastoma cells
por: Xu, Peng-Fei, et al.
Publicado: (2019) -
Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221
por: Zhang, Jianjun, et al.
Publicado: (2016) -
Editorial: In vitro toxicogenomics (TGx) in hazard and risk assessment
por: Beal, Marc A., et al.
Publicado: (2023) -
Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
por: Zillikens, Hannah, et al.
Publicado: (2021)